ProMIS Neurosciences, Inc.
PMNNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $76.25M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $6.27$27.40
- Volume (live)
- -
- Avg. volume (3M)
- 30.37K
ProMIS Neurosciences (PMN) Stock Price & Financial Analysis
ProMIS Neurosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $8.24 - $8.80 |
|---|---|
| 52-Week High | $27.40 |
| 52-Week Low | $6.27 |
| Open | $8.65 |
| Volume (last close) | 10.40K |
| Average Volume (3M) | 30.37K |
| 50-Day MA | $12.23 |
|---|---|
| 200-Day MA | $12.87 |
| 1-Year Change | −16.27% |
| Market Cap | 76.25M |
|---|---|
| Shares Outstanding | 9.14M |
| Price to Book (P/B) | 1.54 |
| EV/EBITDA | -0.67 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
ProMIS Neurosciences at a Glance
As of the Oct 23, 2026 close, ProMIS Neurosciences (PMN) has a market capitalization of $76.25M.
As of its latest reported balance sheet, it holds $53.43M in cash and securities against $0.00 of debt, a net cash position of $53.43M.
ProMIS Neurosciences does not currently pay a dividend.
The share price is down 16.3% over the past year. At $8.34 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $6.27 to $27.40, below its 200-day moving average of $12.87.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $43.00, 415.6% above the Oct 23, 2026 close.
Frequently Asked Questions About ProMIS Neurosciences
What is the current stock price for PMN?
As of the Oct 23, 2026 close, PMN stock trades at $8.34. The 52-week range is $6.27–$27.40, with a day range of $8.24–$8.80.
What is the P/E ratio for PMN?
The P/E ratio (Price-to-Earnings) for PMN is shown in the Key Statistics section. This valuation metric helps compare ProMIS Neurosciences, Inc. to industry peers.
Does PMN pay dividends?
ProMIS Neurosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PMN?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for PMN is Buy. The average 12-month price target is $43.00, a 415.6% upside from the Oct 23, 2026 close of $8.34.
What is the market cap of PMN?
As of the Oct 23, 2026 close, ProMIS Neurosciences's market capitalization is $76.2M, classifying it as a micro-cap company. ProMIS Neurosciences operates in the Healthcare sector within the Biotechnology industry.